Last reviewed · How we verify
NCT04004533
The Development and Evaluation of a Novel Duodenoscope Assessment Tool
trial testing Endoscopic retrograde cholangiopancreatography (ERCP) in Dudoenoscope Assessment Tool in 745 participants. Completed in 31 December 2021.
31 October 2021
Quick facts
| Lead sponsor | AdventHealth |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 745 |
| Start date | 20 May 2019 |
| Primary completion | 31 October 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 9 locations across United States |
Drugs / interventions tested
- Endoscopic retrograde cholangiopancreatography (ERCP)
Conditions studied
- Dudoenoscope Assessment Tool — all drugs for Dudoenoscope Assessment Tool →
Sponsor
AdventHealth — full company profile →
Who can join
18 and older, any sex, with Dudoenoscope Assessment Tool. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Endoscopic retrograde cholangiopancreatography (ERCP) procedures are performed using duodenoscopes for the treatment of pancreatic and biliary diseases. Although outcomes in endoscopic retrograde cholangiopancreatography (ERCP) procedures are measured mainly in terms of procedural success and complications, currently there are no objective tools to assess the technical performance of the duodenoscopes. The Center for Interventional Endoscopy has maintained a multicenter database that prospectively evaluates the technical performance of duodenoscopes for performing ERCPs. Our objective is to analyze the database in order to summarize the technical performance of duodenoscopes during ERCPs and evaluate the reliability of the duodenoscope assessment tool.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prospective evaluation of an assessment tool for technical performance of duodenoscopes.
Bang JY, Rösch T, Kim HM, Thakkar S, et al · · 2021 · cited 7× · PMID 33007136 · DOI 10.1111/den.13856
Verify or expand the search:
- PubMed search for NCT04004533
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endoscopic retrograde cholangiopancreatography (ERCP)
Trials testing the same drug.
- NCT07389915 — A Convolutional Neural Network for Difficult Biliary Cannulation · not yet recruiting
- NCT06670547 — Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography · not yet recruiting
- NCT06964425 — Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study · NA · recruiting
Other AdventHealth trials
Trials by the same sponsor.
- NCT07359352 — Surgical Care And Recovery With Laser Evaluation Trial (SCARLET) · NA · not yet recruiting
- NCT07472127 — Professional Readiness Through Emotional Preparedness (PREP) · NA · not yet recruiting
- NCT07357376 — Evaluating Suzetrigine for Pain Control Following TKA · Phase 3 · not yet recruiting
- NCT07298018 — A Pilot Study of RISE for Nurse Managers Retreat · NA · recruiting
- NCT07081542 — Comparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04004533 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AdventHealth
- Last refreshed: 17 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04004533.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing